{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/mumps/","result":{"data":{"firstChapter":{"id":"6c846669-621b-584b-a875-ab7861474446","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field f79259cd-a39f-4dd4-b409-e4ff80c89ab1 --><h1>Mumps: Summary</h1><!-- end field f79259cd-a39f-4dd4-b409-e4ff80c89ab1 -->","htmlStringContent":"<!-- begin item bd2ff188-928d-4179-b286-81ba24a85410 --><!-- begin field df026b3e-6094-43bb-a5db-234f61fadec5 --><ul><li>Mumps is an acute infectious disease caused by a paramyxovirus, characterised by bilateral parotid swelling. It is spread by respiratory droplets, fomites or saliva. </li><li>The incubation period of mumps is 16-18 days (range 12–25 days).</li><li>It is most infectious from around 1–2 days before onset of symptoms, to about 9 days afterwards, although it may be asymptomatic in 15–20% of people. <ul><li>Asymptomatic mumps infection is common in children.</li></ul></li><li>Nearly all people develop life-long immunity to mumps after one episode of infection. <ul><li>However, 1–2% of cases are thought to be re-infections.</li></ul></li><li>In 2017 in England and Wales, there were 1840 laboratory confirmed cases of mumps.<ul><li>Over 90% of confirmed cases were in people aged 15 years or over. </li></ul></li><li>Clinically, mumps presents with:<ul><li>Parotitis (swollen parotid glands) — this is present in 95% of symptomatic cases. </li><li>Non-specific symptoms of fever, headache, malaise, muscle ache, and loss of appetite.</li><li>Epididymo-orchitis — affects up to 38% of infected men. Unilateral mumps epididymo-orchitis can significantly, but only transiently, diminish the sperm count, mobility, and morphology. Bilateral mumps epididymo-orchitis occurs in 15–30% of affected men and causes infertility in 30–87% of them.</li><li>Oophoritis occurs in about 7% of women, but rarely causes infertility or premature menopause. </li></ul></li><li>Occasionally complications other than diagnostic symptoms can present:<ul><li>Aseptic meningitis. </li><li>Transient hearing loss.</li><li>Pancreatitis.</li><li>Rarer complications include other central nervous system disorders (such as cerebellar ataxia, facial palsy, transverse myelitis, and Guillain–Barre syndrome), thyroiditis, mastitis, prostatitis, hepatitis, and thrombocytopenia.</li></ul></li><li>Mumps is a notifiable disease. If there is any suspicion of infection, the local Health Protection Unit (HPU) should be notified. They will arrange a testing kit for confirmation and surveillance purposes.</li><li>People should be advised:<ul><li>That mumps is usually a self-limiting condition. It will usually resolve over 1–2 weeks, with no long-term consequences and antibiotic treatment is not required. </li><li>To rest, drink adequate fluids, and take paracetamol or ibuprofen for symptomatic relief (aspirin should be avoided in children younger than 16 years of age).</li><li>To apply warm or cold packs to the parotid gland as it may ease discomfort. </li><li>To stay off school or work for 5 days after the initial development of parotitis. </li></ul></li><li>Admission to hospital or referral for specialist advice should be arranged if:<ul><li>There are signs of mumps encephalitis (for example, an altered level or loss of consciousness, focal neurological signs, or seizures).</li><li>The person develops mumps meningitis (characterized by severe headache, neck ache, high fever, lethargy, and vomiting).</li><li>Following epididymo-orchitis (particularly if it was bilateral), a man has an abnormal semen analysis, or is experiencing infertility.</li></ul></li><li>People who have been in contact with possible mumps should be offered immunization with the combined measles, mumps, and rubella (MMR) vaccine if they are not already fully immunized, unless they are pregnant, or severely immunocompromised.</li></ul><!-- end field df026b3e-6094-43bb-a5db-234f61fadec5 --><!-- end item bd2ff188-928d-4179-b286-81ba24a85410 -->","topic":{"id":"7ad4f0a4-06c0-5306-a9ca-a5b09b031c64","topicId":"902223a1-1315-411e-84fd-531be11ff727","topicName":"Mumps","slug":"mumps","aliases":[],"chapters":[{"id":"6c846669-621b-584b-a875-ab7861474446","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"bc7e1c23-92a9-5367-b862-2a2617f05af5","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"0157fa06-8282-526e-af69-8991cca61c73","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ccdc1fa2-87cb-5d4a-b263-e3e087505df6","slug":"changes","fullItemName":"Changes"},{"id":"f29a1db7-bde6-5926-9cd1-4506e75dbc23","slug":"update","fullItemName":"Update"}]},{"id":"2ba6cf96-cc97-5805-869e-4f246942f844","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"aab7106a-3d2a-553c-acf0-6f01361c80d5","slug":"goals","fullItemName":"Goals"},{"id":"fb2fa84b-f74e-51d4-b236-9eb25b81992f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"131735e3-90c2-501e-9fa8-78728aa805cd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1019ae46-5284-52e9-8193-98f211fddbcb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"18ebc501-e7dd-599c-986e-d9b0caee354b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"04d520eb-da4b-5da5-9f2a-c75cf2457a5c","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"32c204d6-a526-5944-ae13-c618c08341c3","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8f24b84c-7b64-5233-a8d2-4d0d65287b78","slug":"definition","fullItemName":"Definition"},{"id":"dd3ba6b4-c053-55da-8d3c-d76d2a4f5217","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3d85f802-c619-5fc1-b5c5-d3677961ed9a","slug":"prognosis","fullItemName":"Prognosis"},{"id":"ded05498-94b3-577b-aa8c-e2e67092abbd","slug":"complications","fullItemName":"Complications"}]},{"id":"b33f0286-8933-5db3-80b9-f7e39b3179a1","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"f74f23fd-8fed-5b0c-91ce-77cdb8579758","slug":"diagnosis-of-mumps","fullItemName":"Diagnosis of mumps"},{"id":"e26c327e-8cea-51e8-8540-f4683c4ba744","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"0e5e75e8-29a9-5521-bef6-406c5cfa0dc9","slug":"management","fullItemName":"Management","subChapters":[{"id":"a2fc78df-8401-5217-9b0f-47bd7e8ebe21","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"fcdd3c2d-0df3-5a00-889b-9f163a4d5613","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"ab0a4d5f-3b95-5890-b7af-a0d9fd531b77","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"834335ef-b56b-5735-8f0e-7fed73f23f59","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"099c1b85-692a-50c0-b94e-0f18285a5937","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"89ed05cf-f337-5698-b93b-3978c44b94ca","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8e27b79e-1ade-557d-b6ef-83480b6f17e5","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5a275a1b-bfba-5b91-8d22-995be0b93406","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"66e55028-d291-5974-9274-e983e158cc1c","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"7ad4f0a4-06c0-5306-a9ca-a5b09b031c64","topicId":"902223a1-1315-411e-84fd-531be11ff727","topicName":"Mumps","slug":"mumps","aliases":[],"topicSummary":"Mumps is a moderate-to-highly contagious acute viral infection caused by a paramyxovirus, and spread by direct contact with saliva.","lastRevised":"Last revised in December 2018","nextPlannedReviewBy":"2023-12-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2023-12","nextPlannedReviewByDisplay":"December 2023","specialities":[{"id":"e9e3ea2b-52b8-5242-bc9d-24052ea8647a","name":"Child health","slug":"child-health"},{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"}],"chapters":[{"id":"6c846669-621b-584b-a875-ab7861474446","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"bc7e1c23-92a9-5367-b862-2a2617f05af5","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"0157fa06-8282-526e-af69-8991cca61c73","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ccdc1fa2-87cb-5d4a-b263-e3e087505df6","slug":"changes","fullItemName":"Changes"},{"id":"f29a1db7-bde6-5926-9cd1-4506e75dbc23","slug":"update","fullItemName":"Update"}]},{"id":"2ba6cf96-cc97-5805-869e-4f246942f844","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"aab7106a-3d2a-553c-acf0-6f01361c80d5","slug":"goals","fullItemName":"Goals"},{"id":"fb2fa84b-f74e-51d4-b236-9eb25b81992f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"131735e3-90c2-501e-9fa8-78728aa805cd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1019ae46-5284-52e9-8193-98f211fddbcb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"18ebc501-e7dd-599c-986e-d9b0caee354b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"04d520eb-da4b-5da5-9f2a-c75cf2457a5c","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"32c204d6-a526-5944-ae13-c618c08341c3","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8f24b84c-7b64-5233-a8d2-4d0d65287b78","slug":"definition","fullItemName":"Definition"},{"id":"dd3ba6b4-c053-55da-8d3c-d76d2a4f5217","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3d85f802-c619-5fc1-b5c5-d3677961ed9a","slug":"prognosis","fullItemName":"Prognosis"},{"id":"ded05498-94b3-577b-aa8c-e2e67092abbd","slug":"complications","fullItemName":"Complications"}]},{"id":"b33f0286-8933-5db3-80b9-f7e39b3179a1","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"f74f23fd-8fed-5b0c-91ce-77cdb8579758","slug":"diagnosis-of-mumps","fullItemName":"Diagnosis of mumps"},{"id":"e26c327e-8cea-51e8-8540-f4683c4ba744","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"0e5e75e8-29a9-5521-bef6-406c5cfa0dc9","slug":"management","fullItemName":"Management","subChapters":[{"id":"a2fc78df-8401-5217-9b0f-47bd7e8ebe21","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"fcdd3c2d-0df3-5a00-889b-9f163a4d5613","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"ab0a4d5f-3b95-5890-b7af-a0d9fd531b77","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"834335ef-b56b-5735-8f0e-7fed73f23f59","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"099c1b85-692a-50c0-b94e-0f18285a5937","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"89ed05cf-f337-5698-b93b-3978c44b94ca","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8e27b79e-1ade-557d-b6ef-83480b6f17e5","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5a275a1b-bfba-5b91-8d22-995be0b93406","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"66e55028-d291-5974-9274-e983e158cc1c","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"7ad4f0a4-06c0-5306-a9ca-a5b09b031c64"}},"staticQueryHashes":["3666801979"]}